<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
68788-8374-8
</NDCCode>
<PackageDescription>
8 PATCH in 1 PACKET (68788-8374-8) / 3.5 d in 1 PATCH
</PackageDescription>
<NDC11Code>
68788-8374-08
</NDC11Code>
<ProductNDC>
68788-8374
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Estradiol
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Estradiol
</NonProprietaryName>
<DosageFormName>
PATCH, EXTENDED RELEASE
</DosageFormName>
<RouteName>
TRANSDERMAL
</RouteName>
<StartMarketingDate>
20230224
</StartMarketingDate>
<EndMarketingDate>
20241001
</EndMarketingDate>
<MarketingCategoryName>
NDA AUTHORIZED GENERIC
</MarketingCategoryName>
<ApplicationNumber>
NDA020538
</ApplicationNumber>
<LabelerName>
Preferred Pharmaceuticals Inc.
</LabelerName>
<SubstanceName>
ESTRADIOL
</SubstanceName>
<StrengthNumber>
.05
</StrengthNumber>
<StrengthUnit>
mg/d
</StrengthUnit>
<Pharm_Classes>
Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2024-10-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20230224
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20241001
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>